欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:
CDK1参与肝细胞癌的发展机制及其抑制剂应用价值
叶凯丽, 郑雯, 叶啟发, 杨岚
Mechanism of CDK1 participates in the development of hepatocellular carcinoma and its inhibitor application value
YE Kaili, ZHENG Wen, YE Qifa, YANG Lan
中国临床药理学与治疗学 . 2021, (9): 1086 -1094 .  DOI: 10.12092/j.issn.1009-2501.2021.09.016